An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Nanotechnology

Background:

• Paclitaxel injection (Taxol) is associated with frequent hypersensitivity reactions.
• There is a clinical need for safer paclitaxel formulations.
• Microemulsions offer potential for improved drug delivery and reduced toxicity.

Purpose of the Study:

• To develop and evaluate a novel paclitaxel microemulsion as an alternative to Taxol.
• To assess the hypersensitivity and pharmacokinetic profiles of the paclitaxel microemulsion in rats.

Main Methods:

• Preparation of a paclitaxel microemulsion with a small particle size (17.2 nm).
• Hypersensitivity evaluation in rats.
• Pharmacokinetic studies in rats using High-Performance Liquid Chromatography (HPLC) for paclitaxel determination.

Main Results:

• The paclitaxel microemulsion showed no hypersensitivity reactions, while the placebo Taxol solution was positive.
• The microemulsion group exhibited a significantly higher Area Under the Curve (AUC) (34.98 microg ml(-1) h) compared to the Taxol group (21.98 microg ml(-1) h).
• The elimination rate constant (K(10)) was lower in the microemulsion group (0.57 h(-1)) versus the Taxol group (1.29 h(-1)), indicating slower elimination.

Conclusions:

• The developed paclitaxel microemulsion is a promising alternative formulation with reduced hypersensitivity.
• The microemulsion demonstrates favorable pharmacokinetics, including a longer circulation time and lower toxicity in rats compared to Taxol.